Sanara MedTech (SMTI) Competitors $33.51 +0.51 (+1.55%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SMTI vs. PLSE, BVS, AVNS, BLFS, MDXG, LQDA, EMBC, EYE, CATX, and IRMDShould you be buying Sanara MedTech stock or one of its competitors? The main competitors of Sanara MedTech include Pulse Biosciences (PLSE), Bioventus (BVS), Avanos Medical (AVNS), BioLife Solutions (BLFS), MiMedx Group (MDXG), Liquidia (LQDA), Embecta (EMBC), National Vision (EYE), Perspective Therapeutics (CATX), and Iradimed (IRMD). These companies are all part of the "medical equipment" industry. Sanara MedTech vs. Pulse Biosciences Bioventus Avanos Medical BioLife Solutions MiMedx Group Liquidia Embecta National Vision Perspective Therapeutics Iradimed Pulse Biosciences (NASDAQ:PLSE) and Sanara MedTech (NASDAQ:SMTI) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, community ranking, profitability, institutional ownership and media sentiment. Do analysts prefer PLSE or SMTI? Sanara MedTech has a consensus price target of $44.00, suggesting a potential upside of 31.30%. Given Sanara MedTech's higher probable upside, analysts clearly believe Sanara MedTech is more favorable than Pulse Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ASanara MedTech 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in PLSE or SMTI? Pulse Biosciences received 229 more outperform votes than Sanara MedTech when rated by MarketBeat users. Likewise, 64.49% of users gave Pulse Biosciences an outperform vote while only 54.55% of users gave Sanara MedTech an outperform vote. CompanyUnderperformOutperformPulse BiosciencesOutperform Votes24764.49% Underperform Votes13635.51% Sanara MedTechOutperform Votes1854.55% Underperform Votes1545.45% Which has more risk and volatility, PLSE or SMTI? Pulse Biosciences has a beta of 1.74, suggesting that its share price is 74% more volatile than the S&P 500. Comparatively, Sanara MedTech has a beta of 1.58, suggesting that its share price is 58% more volatile than the S&P 500. Does the media favor PLSE or SMTI? In the previous week, Pulse Biosciences had 11 more articles in the media than Sanara MedTech. MarketBeat recorded 12 mentions for Pulse Biosciences and 1 mentions for Sanara MedTech. Pulse Biosciences' average media sentiment score of 0.48 beat Sanara MedTech's score of 0.00 indicating that Pulse Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulse Biosciences 3 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sanara MedTech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger valuation & earnings, PLSE or SMTI? Sanara MedTech has higher revenue and earnings than Pulse Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPulse Biosciences$700K1,274.83-$42.21MN/AN/ASanara MedTech$64.99M4.51-$4.30M-$0.78-42.96 Do insiders and institutionals hold more shares of PLSE or SMTI? 76.9% of Pulse Biosciences shares are held by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are held by institutional investors. 71.5% of Pulse Biosciences shares are held by insiders. Comparatively, 54.1% of Sanara MedTech shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is PLSE or SMTI more profitable? Pulse Biosciences has a net margin of 0.00% compared to Sanara MedTech's net margin of -9.07%. Sanara MedTech's return on equity of -15.17% beat Pulse Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Pulse BiosciencesN/A -126.10% -91.24% Sanara MedTech -9.07%-15.17%-8.94% SummaryPulse Biosciences beats Sanara MedTech on 9 of the 15 factors compared between the two stocks. Ad Timothy SykesCountdown to the biggest trade of my 25 yr careerTim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why Get Sanara MedTech News Delivered to You Automatically Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMTI vs. The Competition Export to ExcelMetricSanara MedTechSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$293.21M$9.32B$5.32B$8.52BDividend YieldN/A1.05%5.07%4.13%P/E Ratio-42.9622.41127.5316.08Price / Sales4.5139.611,490.6892.20Price / CashN/A27.2339.5134.18Price / Book6.425.774.765.07Net Income-$4.30M$181.29M$118.77M$225.46M7 Day Performance5.71%-3.14%-0.38%0.06%1 Month Performance15.55%-7.93%6.06%3.93%1 Year Performance25.46%3.26%38.14%32.50% Sanara MedTech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMTISanara MedTech1.6357 of 5 stars$33.51+1.5%$44.00+31.3%+25.5%$288.65M$64.99M-42.9660News CoveragePLSEPulse Biosciences1.4135 of 5 stars$17.62-1.7%N/A+232.4%$1.08B$700,000.00-21.75140Earnings ReportNews CoverageBVSBioventus1.7495 of 5 stars$13.21-1.0%$12.00-9.2%+276.2%$1.05B$536.89M-20.011,200Upcoming EarningsAVNSAvanos Medical3.5022 of 5 stars$22.34+0.5%N/A-10.0%$1.03B$673.30M131.413,771Earnings ReportNews CoverageBLFSBioLife Solutions1.3451 of 5 stars$22.03+1.9%$26.67+21.0%+135.3%$1.01B$139.96M-13.04409News CoveragePositive NewsMDXGMiMedx Group4.0266 of 5 stars$5.85+2.5%$12.00+105.1%+7.4%$863.48M$340.46M10.45870Analyst UpgradeAnalyst RevisionNews CoverageLQDALiquidia3.8829 of 5 stars$11.01-0.4%$24.67+124.0%+66.6%$845.46M$17.49M-7.0150Upcoming EarningsEMBCEmbecta1.1956 of 5 stars$13.90-1.1%$12.00-13.7%-6.1%$801.61M$1.12B11.582,200Short Interest ↑EYENational Vision3.6971 of 5 stars$9.79+0.6%$15.25+55.8%-29.4%$761.19M$2.13B-9.5013,998Upcoming EarningsShort Interest ↑CATXPerspective Therapeutics3.0247 of 5 stars$11.53-3.0%$20.63+78.9%N/A$717.89M$1.43M0.00116IRMDIradimed4.8625 of 5 stars$50.39-0.2%$60.00+19.1%+17.6%$638.44M$65.56M34.51110Dividend AnnouncementNews Coverage Related Companies and Tools Related Companies Pulse Biosciences Competitors Bioventus Competitors Avanos Medical Competitors BioLife Solutions Competitors MiMedx Group Competitors Liquidia Competitors Embecta Competitors National Vision Competitors Perspective Therapeutics Competitors Iradimed Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SMTI) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanara MedTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanara MedTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SMTI Stock Alerts